CAS: 125228-51-5
![N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide](https://static.cymitquimica.com/products/3D/thumb/AFA22851.jpg)
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide
CAS:125228-51-5
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.0914]heptacos an-16yl)-2hydroxy 2-[2hydroxy 6methyl 5-(2methylbutyl)oxan 2yl]propanamide is a synthetic cyclic lipopeptide that inhibits the activity …
Fórmula:
C38H64N8O13
Pureza:
Min. 95%
Peso molecular:
841 g/mol
Ref: 3D-AFA22851
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 15 de Julio de 2024
